• Microplastics, DHEA Models, and the Gut–Vitamin B6 Axis

  2026-10-01

  A recent mouse study identifies a gut microbiota–vitamin B6–ovary pathway through which polystyrene microplastics worsen DHEA-induced polycystic ovary syndrome. The findings connect microbial vitamin depletion with ovarian inflammation, oxidative stress, endocrine disruption, and partial rescue by vitamin B6 supplementation.

• SW033291: From 15-PGDH Kinetics to Repair

  2026-10-01

  SW033291 is a potent 15-PGDH inhibitor for dissecting prostaglandin E2 elevation, hematopoiesis, and tissue repair. This article presents an assay-to-model framework that separates target engagement from regenerative phenotype and clarifies how recent muscle-repair evidence should guide experimental design.

• Crizotinib Hydrochloride in Tumor Assembloids

  2026-09-30

  Crizotinib hydrochloride provides a precise pharmacologic probe for ALK, ROS1, and c-Met signaling in complex tumor models. This article explains how patient-derived gastric cancer assembloids can distinguish tumor-cell target engagement from stromal modulation of drug response.

• Spermine Tetrahydrochloride: Charge to Function

  2026-09-30

  Spermine tetrahydrochloride is more than a polyamine additive: its ionic behavior can alter membrane protection, protein crystallization, and nanoparticle architecture. This guide translates charge-mediated interactions into practical assay and formulation decisions.

• YZ462 Disrupts MRSA Membranes and Biofilms

  2026-09-29

  The 2025 BMC Microbiology study identifies YZ462 as a heteroaromatic–aryl small molecule with activity against methicillin-resistant Staphylococcus aureus (MRSA). Its proposed mechanism combines membrane disruption, increased permeability, endogenous reactive oxygen species production, and interaction with cardiolipin, with efficacy extending to stationary-phase bacteria and biofilms.

• HyperFluor 488 Goat Anti-Mouse IgG Guide

  2026-09-29

  This scenario-based guide explains how HyperFluor™ 488 Goat Anti-Mouse IgG (H+L) Antibody, SKU K1204, can support reproducible immunofluorescence, flow cytometry, and western blot workflows associated with viability, proliferation, and cytotoxicity studies. It connects product specifications with practical controls, storage decisions, and interpretation limits.

• Rifampin Workflows for Bacterial Transcription Studies

  2026-09-28

  Rifampin provides a direct way to perturb bacterial transcription, connect viability loss with RNA-polymerase inhibition, and investigate resistance under controlled exposure. This workflow-focused guide covers stock preparation, time-course assays, resistance studies, synthetic biology applications, and troubleshooting for reproducible results.

• Clozapine in Cell Assays: Practical Design Guide

  2026-09-28

  A scenario-driven guide to using Clozapine (SKU B2235) in cell viability, signaling, and hepatotoxicity studies. It connects receptor and ERK1/2 evidence with practical dose, vehicle, assay-interpretation, and product-selection considerations for schizophrenia research.

• SEMA3E Promotes Beige Fat Thermogenesis via β-Catenin

  2026-09-27

  A mouse study identifies SEMA3E as a regulator of beige adipocyte differentiation and thermogenesis, linking its effects to mitochondrial oxidative phosphorylation and β-catenin signaling. The findings support further investigation of SEMA3E in adipose biology while leaving the precise pathway dynamics and relevance to human tissue unresolved.

• Fzd5 Connects Cholesterol to Wnt Signaling in PDAC

  2026-09-26

  The study identifies Frizzled5 (Fzd5) as a cholesterol-binding Wnt receptor and links cholesterol recognition to receptor palmitoylation, cell-surface trafficking, and Wnt/β-catenin activity in pancreatic cancer models. It provides a mechanistic explanation for how altered lipid metabolism can support Wnt-dependent tumor growth, while positioning cholesterol competition as a preclinical research avenue rather than an established treatment.

• Pertussis toxin: workflows for signaling research

  2026-09-25

  Pertussis toxin offers researchers a way to probe Gi/o-linked signaling, from immune assays to a behaviorally distinct test of serotonergic dose responses. This guide translates a mouse study into practical workflow choices while separating its reported conditions from assay-design recommendations.

• AP20187: Chemical Inducer of Dimerization Workflows

  2026-09-25

  AP20187 gives researchers a controllable way to activate engineered fusion proteins, with practical uses in reporter assays, conditional signaling, and regulated cell therapy research. Here, workflows are framed alongside a chronic intermittent hypoxia study—while clearly separating its macrophage findings from AP20187 applications that would require new engineered models.

• Deferoxamine Mesylate in Iron-Redox Assays

  2026-09-24

  Use Deferoxamine mesylate to probe how iron availability shapes oxidative-stress, HIF-1α, and tissue-protection readouts. A practical workflow pairs dose controls with rapid ROS measurements—while keeping clear that the featured platinum study does not establish an iron-dependent mechanism.

• Tricine-SDS-PAGE Gel Preparation Kit for Peptides

  2026-09-24

  This kit supports protein electrophoresis and peptide separation when conventional Tris-SDS-PAGE does not adequately resolve low-molecular-weight targets. It is intended for research gel preparation and denaturing or non-denaturing workflows, not diagnostic, clinical, or medical testing.

• Indomethacin for Inflammation Research Workflows

  2026-09-23

  Use Indomethacin to probe cyclooxygenase-dependent inflammatory signaling alongside pathways such as FXR–KLF11–JAK2/STAT3—not as a substitute for testing those pathways directly. This workflow combines dose-response design, vehicle controls, and orthogonal readouts to help distinguish COX inhibition from broader cellular effects.

8670 records 4/578 page Previous Next 12345 下5页 Last page